Stephanie Hopley

Stephanie Hopley is the VP Drug Discovery at Apollo Therapeutics since June 2021. Prior to this, Stephanie held the position of Project Director at Apollo Therapeutics LLP from February 2019 to June 2021. Stephanie also worked at Tusk Therapeutics as a Principal Scientist and Project Manager from January 2018 to February 2019. Stephanie's extensive experience includes roles at GSK from 2004 to December 2017, where Stephanie held various titles including Scientific Leader, Team Leader, and Senior Scientist. Stephanie also worked as a Marie Curie Postdoctoral Fellow at Swedish Orphan Biovitrum AB from 2002 to 2004, focusing on research related to expressing a difficult protein in E. Stephanie holds a Ph.D. in Biochemistry from the University of Birmingham.